CoreValve Advance, International Post Market Study A Multi-center, Interventional, Prospective, Post-Market Release Study - CoreValve Advance

Medtronic B.V.0 个研究点目标入组 250 人开始时间: 待定最近更新: 2024年6月24日

适应症

试验速览

暂无简介。

•1. Patient with severe aortic valve stenosis requiring treatment.
•2. Patient is an acceptable candidate for elective treatment with the Medtronic CoreValve System and in conformity with the local regulatory and medico economic context.
•3. Patient is above the minimum age as required by local regulations to be participating in a clinical study.
•4. The patient has been informed of the nature of the study and has consented to participate, and has authorized the collection and release of his/her medical information by signing a consent form (*Patient Informed Consent Form*)

•1. Currently participating in another trial
•2. High probability of non-adherence to the follow-up requirements (due to social, psychological or medical reasons)
•3. Pregnancy

发起方